Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 27;30(7):1480.
doi: 10.3390/molecules30071480.

Biological Activity of Monoterpene-Based Scaffolds: A Natural Toolbox for Drug Discovery

Affiliations
Review

Biological Activity of Monoterpene-Based Scaffolds: A Natural Toolbox for Drug Discovery

Jarosław Mołdoch et al. Molecules. .

Abstract

One of the most common strategies used in drug design is the molecular scaffold approach, which combines traditional medicine based on natural active compounds derived from plants with modern synthetic drug development. Designing new compounds based on natural skeletons enables extensive modifications of both bioavailability and biological activity. An excellent example of a natural molecular scaffold is the monoterpenes group, which serves as a core structure for building more complex molecules by attaching various chemical groups. Their ability to interact with biological targets, combined with structural versatility, makes them promising molecular scaffolds in pharmaceutical research and green chemistry applications. This review paper focuses on selected monoterpenes (carvacrol, carvone, citral, menthol, menthone, β-pinene, thymol, and verbenone), which are frequently used as molecular scaffolds. The newly designed derivatives exhibit various biological activities, including anticancer, antibacterial, antiviral, neuroprotective, and many others.

Keywords: carvacrol; carvone; citral; menthol; menthone; molecular scaffold; monoterpenes; thymol; verbenone; β-pinene.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structures of monoterpenes presented in the paper as molecular scaffolds.
Figure 2
Figure 2
Carvacrol derivatives.
Figure 3
Figure 3
Carvone derivatives.
Figure 4
Figure 4
Citral derivatives.
Figure 5
Figure 5
Menthol derivatives.
Figure 6
Figure 6
β-pinene’s derivatives.
Figure 7
Figure 7
Thymol’s derivatives.
Figure 8
Figure 8
Verbenone derivatives.
Figure 9
Figure 9
Menthone derivatives.

Similar articles

Cited by

References

    1. Doytchinova I. Drug Design—Past, Present, Future. Molecules. 2022;27:1496. doi: 10.3390/molecules27051496. - DOI - PMC - PubMed
    1. Bemis G.W., Murcko M.A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996;39:2887–2893. doi: 10.1021/jm9602928. - DOI - PubMed
    1. Hu Y., Stumpfe D., Bajorath J. Lessons Learned from Molecular Scaffold Analysis. J. Chem. Inf. Model. 2011;51:1742–1753. doi: 10.1021/ci200179y. - DOI - PubMed
    1. Lv Y., Zheng Z., Liu R., Guo J., Zhang C., Xie Y. Monoamine Oxidase B Inhibitors Based on Natural Privileged Scaffolds: A Review of Systematically Structural Modification. Int. J. Biol. Macromol. 2023;251:126158. doi: 10.1016/j.ijbiomac.2023.126158. - DOI - PubMed
    1. Vina D., Serra S., Lamela M., Delogu G. Herbal Natural Products As a Source of Monoamine Oxidase Inhibitors: A Review. Curr. Top. Med. Chem. 2012;12:2131–2144. doi: 10.2174/1568026611212200003. - DOI - PubMed

MeSH terms

LinkOut - more resources